Result Summaries: Salmeterol/Fluticasone
| GSK Study ID |
Phase | Title | Summary (Download) |
|---|---|---|---|
| 113063 | Phase 4 | Summing up the effectiveness and safety by using Seretide Diskus Powder inhalator 2 times daily 50/250mg for patients with moderate/serious Asthma (0 citation(s)) |  |